{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:25:21Z","timestamp":1776759921374,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neurofibromatosis type 1 is an inherited cancer predisposition syndrome that is caused by a mutation in the <jats:italic>NF1<\/jats:italic> gene that encodes neurofibromin. Patients with neurofibromatosis type 1 have a higher risk of gastrointestinal stromal tumor. This study reports the case of a patient with gastrointestinal stromal tumor who was later diagnosed to have neurofibromatosis type 1 and, unlike usual features, had some uncommon features such as occurrence at an early age and unusual site of origin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case<\/jats:title>\n                <jats:p>We report the case of a 29-year-old Indian female diagnosed to have gastrointestinal stromal tumor originating from the greater curvature of the stomach. Gastrointestinal stromal tumor was wild type, negative for c-kit and platelet-derived growth factor receptor, and had an aggressive clinical course not responding to oral tyrosine kinase inhibitors. On later evaluation, we found that the patient had germline mutation in <jats:italic>NF1<\/jats:italic>. This case has some unusual features compared with gastrointestinal stromal tumor cases reported in neurofibromatosis type 1. Firstly, the age of onset for gastrointestinal stromal tumor in neurofibromatosis type 1 is earlier in our case compared with previous cases reported in literature. Secondly, the site of occurrence is in the stomach, without involving other parts of the intestine. Gastrointestinal stromal tumor in neurofibromatosis type 1 is usually multifocal, and small intestine is the common site of occurrence. When occurring in the stomach, it is usually associated with other lesions in the small intestine. Lastly, the clinical course is aggressive compared with previous case reports and series.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our patient had germline <jats:italic>NF1<\/jats:italic> mutation and cutaneous stigmata of neurofibromatosis. Our patient had unicentric gastrointestinal stromal tumor occurring at younger age and involving greater curvature of the stomach, with spindle cell type histology and high-risk features. If gastrointestinal stromal tumor occurs at young age, we should look into neurocutaneous markers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03382-y","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T01:02:31Z","timestamp":1651366951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenges in the management of metastatic gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"B. G.","family":"Bharath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-3083","authenticated-orcid":false,"given":"Sameer","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Barwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,1]]},"reference":[{"issue":"5350","key":"3382_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577\u201380. https:\/\/doi.org\/10.1126\/science.279.5350.577.","journal-title":"Science"},{"issue":"9","key":"3382_CR2","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1002\/mgg3.927","volume":"7","author":"H Yl\u00e4-Outinen","year":"2019","unstructured":"Yl\u00e4-Outinen H, Loponen N, Kallionp\u00e4\u00e4 RA, Peltonen S, Peltonen J. Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST). Mol Genet Genomic Med. 2019;7(9):e927. https:\/\/doi.org\/10.1002\/mgg3.927.","journal-title":"Mol Genet Genomic Med"},{"key":"3382_CR3","first-page":"284","volume":"42","author":"VM Riccardi","year":"1988","unstructured":"Riccardi VM, Lewis RA. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet. 1988;42:284\u20139.","journal-title":"Am J Hum Genet"},{"key":"3382_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.055772","volume":"45","author":"E Denayer","year":"2008","unstructured":"Denayer E, de Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet. 2008;45:695\u2013703.","journal-title":"J Med Genet"},{"key":"3382_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11605-009-0940-5","volume":"14","author":"U Basile","year":"2010","unstructured":"Basile U, Cavallaro G, Polistena A, et al. Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg. 2010;14:186\u201394.","journal-title":"J Gastrointest Surg"},{"key":"3382_CR6","first-page":"1293","volume":"15","author":"T Nishida","year":"2000","unstructured":"Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol. 2000;15:1293\u2013301.","journal-title":"Histol Histopathol"},{"key":"3382_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","volume":"151","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000;151:33\u201340.","journal-title":"Am J Epidemiol"},{"key":"3382_CR8","unstructured":"McNamara L. Neurofibromatosis, Neurofibromatosis 1, NF1, Neurofibromatosis 2, NF2, von Recklinghausen Disease. https:\/\/www.hopkinsmedicine.org\/neurology_neurosurgery\/centers_clinics\/pediatricm\/neurology\/conditions\/neurofibromatosis\/nf2.html. Accessed 22 June 2021."},{"key":"3382_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","volume":"70","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70:138\u201343.","journal-title":"Am J Med Genet"},{"key":"3382_CR10","first-page":"797","volume":"104","author":"J Barahona-Giarrido","year":"2009","unstructured":"Barahona-Giarrido J, Aguirre-Gutierrez R, Gutierrez-Manjarrez JI, et al. Association of GIST and somatostatinoma in a patient with type-1 neurofibromatosis: is there a common pathway? Am J Gastroenterol. 2009;104:797\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"15_suppl","key":"3382_CR11","doi-asserted-by":"publisher","first-page":"11035","DOI":"10.1200\/JCO.2019.37.15_suppl.11035","volume":"37","author":"VR Bulusu","year":"2019","unstructured":"Bulusu VR, et al. Neurofibromatosis 1 (NF1) and gastrointestinal stromal tumors (GISTs): five-year experience from a regional center in United Kingdom. J Clin Oncol. 2019;37(15_suppl):11035. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.11035.","journal-title":"J Clin Oncol"},{"key":"3382_CR12","unstructured":"Gastrointestinal stromal tumors of the duodenum: surgical management and survival results. Accessed 16 Apr 2021."},{"key":"3382_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/01.pas.0000159775.77912.15","volume":"29","author":"J Andersson","year":"2005","unstructured":"Andersson J, Sihto H, Meis-Kindblom JM, et al. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol. 2005;29:1170\u20136. https:\/\/doi.org\/10.1097\/01.pas.0000159775.77912.15.","journal-title":"Am J Surg Pathol"},{"key":"3382_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/annonc\/mdi127","volume":"16","author":"JY Blay","year":"2005","unstructured":"Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20\u201321 March 2004, under the auspices of ESMO. Ann Oncol. 2005;16:566\u201378.","journal-title":"Ann Oncol"},{"issue":"15_suppl","key":"3382_CR15","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.1200\/JCO.2019.37.15_suppl.11006","volume":"37","author":"P Schoffski","year":"2019","unstructured":"Schoffski P, et al. Activity and safety of cabozantinib in patients with gastrointestinal stromal tumor after failure of imatinib and sunitinib: EORTC phase II trial 1317 CaboGIST. J Clin Oncol. 2019;37(15_suppl):11006. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.11006.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03382-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03382-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03382-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T01:03:13Z","timestamp":1651366993000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03382-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3382"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03382-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]},"assertion":[{"value":"7 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}